Status:
COMPLETED
Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
Lead Sponsor:
Abbott
Conditions:
HIV Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to obtain a preliminary assessment of the antiviral activity and tolerability of simplified Kaletra dual agent therapy as initial treatment for HIV infection, relative to ...
Eligibility Criteria
Inclusion
- HIV positive
- \>18 years of age
- HIV RNA\> 400 copies/mL
- Any CD 4 cell count
- Antiretroviral naïve
- No acute illness
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00234910
Start Date
January 1 2005
End Date
June 1 2008
Last Update
July 10 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Global Medical Information-Abbott
Abbott Park, Illinois, United States, 60064